Papers and publications

EDP-938 : RSV inhibitor as a potential treatment intervention?

Alaa Ahmad, Ph.D., Kingsley Eze, B.Sc., Nicolas Noulin, Ph.D., Veronika Horvathova, M.B., Ch.B., Bryan Murray, M.B., B.S., Mark Baillet, B.Sc., C.Stat., Laura Grey, Ph.D., Julie Mori, Ph.D., and Nathalie Adda

Adda et al. investigated a potential inhibitor of respiratory syncytial virus (RSV) in a human challenge study. An inhibitor, known as EDP-938, would act in such a way whereby it would alter and interfere with a protein that allows for RSV to replicate in the human...

read more

The drivers of the RSV rebound during the COVID-19 pandemic.

You Li, PhD, Xin Wang, PhD, Bingbing Cong, BMed, Shuyu Deng, BMed, Daniel R Feikin, MD, Harish Nair, PhDYou Li and co-workers investigated why RSV has rebounded after the expected local RSV season in several countries during the COVID-19 pandemic. The RSV epidemic was late in the 18 countries included, and 11 observed a rebound before September 2021. The risk of observing a rebound of RSV was 23 times higher after re-opening schools. On the contrary, an increase in temperature of 5°C decreas […]

read more

Publications Archive

Find older publications in our publications archive.